[go: up one dir, main page]

GT200900241A - Compuestos amino-5-[-4-(difluorometoxi )fenil sustituido]-5-fenilimidazolona como inhidibidores de beta secretasa - Google Patents

Compuestos amino-5-[-4-(difluorometoxi )fenil sustituido]-5-fenilimidazolona como inhidibidores de beta secretasa

Info

Publication number
GT200900241A
GT200900241A GT200900241A GT200900241A GT200900241A GT 200900241 A GT200900241 A GT 200900241A GT 200900241 A GT200900241 A GT 200900241A GT 200900241 A GT200900241 A GT 200900241A GT 200900241 A GT200900241 A GT 200900241A
Authority
GT
Guatemala
Prior art keywords
beta
inhidibers
difluorometoxi
amino
phenylimidazolone
Prior art date
Application number
GT200900241A
Other languages
English (en)
Inventor
Michael Sotirios Malamas
Albert Jean Robichaud
Alexander Michael Porte
William Ronald Solvibile
Koi Michele Morris
Schuyler Adam Antane
Ji-In Kim
Robert Emmett Mcdevitt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200900241A publication Critical patent/GT200900241A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS AMINO-5-[-4-(DIFLUOROMETOXI )FENIL SUSTITUIDO]-5-FENILIMIDAZOLONA COMO INHIDIBIDORES DE BETA SECRETASA POR LO QUE SON DE UTILIDAD EN CUADROS O TRASTORNOS ASOCIADOS CON DEPOSITOS BETA-AMILOIDES Y OVILLOS NEUROFIBRILARES, QUE INCLUYEN EL ALZHEIMER, TRISOMIA 21, HEMORRAGIA CEREBRAL Y OTROS TRASTORNOS NEURODEGENERATIVOS.
GT200900241A 2007-03-20 2009-09-10 Compuestos amino-5-[-4-(difluorometoxi )fenil sustituido]-5-fenilimidazolona como inhidibidores de beta secretasa GT200900241A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91908707P 2007-03-20 2007-03-20

Publications (1)

Publication Number Publication Date
GT200900241A true GT200900241A (es) 2010-05-07

Family

ID=39564223

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200900241A GT200900241A (es) 2007-03-20 2009-09-10 Compuestos amino-5-[-4-(difluorometoxi )fenil sustituido]-5-fenilimidazolona como inhidibidores de beta secretasa

Country Status (24)

Country Link
US (1) US20090042964A1 (es)
EP (1) EP2137161A1 (es)
JP (1) JP2010522235A (es)
KR (1) KR20100015376A (es)
CN (1) CN101641335A (es)
AR (1) AR065811A1 (es)
AU (1) AU2008229327A1 (es)
BR (1) BRPI0808944A2 (es)
CA (1) CA2681243A1 (es)
CL (1) CL2008000784A1 (es)
CO (1) CO6140056A2 (es)
CR (1) CR11020A (es)
EC (1) ECSP099639A (es)
GT (1) GT200900241A (es)
IL (1) IL200961A0 (es)
MX (1) MX2009009699A (es)
NI (1) NI200900164A (es)
PA (1) PA8772701A1 (es)
PE (1) PE20090160A1 (es)
RU (1) RU2009133807A (es)
SV (1) SV2009003373A (es)
TW (1) TW200845965A (es)
WO (1) WO2008115552A1 (es)
ZA (1) ZA200906542B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7592348B2 (en) 2003-12-15 2009-09-22 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7700603B2 (en) 2003-12-15 2010-04-20 Schering Corporation Heterocyclic aspartyl protease inhibitors
AU2006259572A1 (en) 2005-06-14 2006-12-28 Schering Corporation Aspartyl protease inhibitors
US8450308B2 (en) 2008-08-19 2013-05-28 Vitae Pharmaceuticals, Inc. Inhibitors of beta-secretase
EP2184276A1 (en) * 2008-11-07 2010-05-12 Universite Paul Cezanne Aix-Marseille Iii Process to prepare new substituted 1H-Benzo(d) imidazol-2(3h)-Ones, New intermediates and their use as bace 1 inhibitors
AU2010223937B2 (en) 2009-03-13 2015-01-22 Vitae Pharmaceuticals, Inc. Inhibitors of beta-secretase
UA108363C2 (uk) 2009-10-08 2015-04-27 Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
WO2011106414A1 (en) 2010-02-24 2011-09-01 Dillard Lawrence W Inhibitors of beta-secretase
US9145426B2 (en) 2011-04-07 2015-09-29 Merck Sharp & Dohme Corp. Pyrrolidine-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
US9221839B2 (en) 2011-04-07 2015-12-29 Merck Sharp & Dohme Corp. C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
CN103874496A (zh) 2011-08-22 2014-06-18 默沙东公司 作为bace抑制剂的2-螺-取代的亚氨基噻嗪类及其单和二氧化物、组合物及其用途
TWI557112B (zh) 2012-03-05 2016-11-11 百靈佳殷格翰國際股份有限公司 β－分泌酶抑制劑
TW201422592A (zh) 2012-08-27 2014-06-16 Boehringer Ingelheim Int β－分泌酶抑制劑
JP2015532282A (ja) 2012-09-28 2015-11-09 ヴァイティー ファーマシューティカルズ，インコーポレイテッド β−セクレターゼの阻害剤
WO2014127042A1 (en) 2013-02-12 2014-08-21 Buck Institute For Research On Aging Hydantoins that modulate bace-mediated app processing
US20160298151A1 (en) 2015-04-09 2016-10-13 Sher Ali Butt Novel Method for the cheap, efficient, and effective production of pharmaceutical and therapeutic api's intermediates, and final products
AU2019257606B2 (en) * 2018-04-23 2025-01-30 Msd Werthenstein Biopharma Gmbh Novel process for synthesis of a phenoxy diaminopyrimidine compound
CN109289696B (zh) * 2018-10-29 2022-03-22 天津先光化工有限公司 一种咪唑啉两性表面活性剂的制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45198B1 (en) * 1976-06-05 1982-07-14 Wyeth John & Brother Ltd Guanidine derivatives
GB1588096A (en) * 1978-05-20 1981-04-15 Wyeth & Bros Ltd John Pyrrole derivatives
GB9511694D0 (en) * 1995-06-09 1995-08-02 Fujisawa Pharmaceutical Co Benzamide derivatives
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
US6492408B1 (en) * 1999-07-21 2002-12-10 Boehringer Ingelheim Pharmaceuticals, Inc. Small molecules useful in the treatment of inflammatory disease
DE10046993A1 (de) * 2000-09-22 2002-04-11 Aventis Pharma Gmbh Substituierte Zimtsäureguanidide, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltendes Medikament
WO2003094854A2 (en) * 2002-05-07 2003-11-20 Elan Pharmaceuticals, Inc. Succinoyl aminopyrazoles and related compounds
US7700603B2 (en) * 2003-12-15 2010-04-20 Schering Corporation Heterocyclic aspartyl protease inhibitors
CN1997646A (zh) * 2004-06-16 2007-07-11 惠氏公司 作为β－分泌酶抑制剂的二苯基咪唑并嘧啶胺和二苯基咪唑并咪唑胺
CN1968945A (zh) * 2004-06-16 2007-05-23 惠氏公司 用于抑制β分泌酶的氨基－5,5－二苯基咪唑酮衍生物
CN101103034A (zh) * 2005-01-14 2008-01-09 惠氏公司 抑制β-分泌酶的氨基-咪唑酮
KR20070107062A (ko) * 2005-02-01 2007-11-06 와이어쓰 β-세크리타제의 억제제로서의 아미노-피리딘
WO2006088705A1 (en) * 2005-02-14 2006-08-24 Wyeth Terphenyl guanidines as [beta symbol] -secretase inhibitors
WO2006088694A1 (en) * 2005-02-14 2006-08-24 Wyeth SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS
JP2008530103A (ja) * 2005-02-14 2008-08-07 ワイス β−セクレターゼ阻害剤としてのアゾリルアシルグアニジン
TW200738683A (en) * 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
CN101213183A (zh) * 2005-06-30 2008-07-02 惠氏公司 氨基-5-(6元)杂芳基咪唑酮化合物和在β-分泌酶调节中的用途
TW200730523A (en) * 2005-07-29 2007-08-16 Wyeth Corp Cycloalkyl amino-hydantoin compounds and use thereof for β-secretase modulation
KR20080050430A (ko) * 2005-09-26 2008-06-05 와이어쓰 베타-세크레타제 (ｂａｃｅ) 억제제로서아미노-5-[4-(디플루오로메톡시)페닐]-5-페닐이미다졸론화합물
CA2634037A1 (en) * 2005-12-19 2007-07-12 Wyeth 2-amino-5-piperidinylimidazolone compounds and use thereof for .beta.-secretase modulation
WO2007100536A1 (en) * 2006-02-24 2007-09-07 Wyeth DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
US7700606B2 (en) * 2006-08-17 2010-04-20 Wyeth Llc Imidazole amines as inhibitors of β-secretase
CA2662348A1 (en) * 2006-09-21 2008-03-27 Wyeth Indolylalkylpyridin-2-amines for the inhibition of .beta.-secretase

Also Published As

Publication number Publication date
AU2008229327A1 (en) 2008-09-25
CO6140056A2 (es) 2010-03-19
ECSP099639A (es) 2009-10-30
IL200961A0 (en) 2010-05-17
CA2681243A1 (en) 2008-09-25
AU2008229327A8 (en) 2009-10-15
WO2008115552A1 (en) 2008-09-25
TW200845965A (en) 2008-12-01
RU2009133807A (ru) 2011-04-27
ZA200906542B (en) 2010-06-30
CL2008000784A1 (es) 2008-05-30
JP2010522235A (ja) 2010-07-01
CR11020A (es) 2009-10-06
PA8772701A1 (es) 2008-11-19
MX2009009699A (es) 2009-09-24
NI200900164A (es) 2010-07-29
SV2009003373A (es) 2010-08-10
PE20090160A1 (es) 2009-02-11
BRPI0808944A2 (pt) 2014-09-02
KR20100015376A (ko) 2010-02-12
CN101641335A (zh) 2010-02-03
AR065811A1 (es) 2009-07-01
US20090042964A1 (en) 2009-02-12
EP2137161A1 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
GT200900241A (es) Compuestos amino-5-[-4-(difluorometoxi )fenil sustituido]-5-fenilimidazolona como inhidibidores de beta secretasa
CO7111287A2 (es) Composiciones plaguicidas y procesos relacionados
MX2009011456A (es) Aumento de la productividad de las plantas por combinacion de agentes quimicos con modificaciones transgenicas.
ATE534717T1 (de) Anzeigesystem
FR3053215B3 (fr) Module d'assemblage de piece montee et structure correspondante.
TH1701005902A (th) องค์ประกอบต้านจุลชีพ
TH701004739A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701005247A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701001838A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701002130A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701002817A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701003380A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701003454A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH703000847A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701001063A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701001480A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701005335A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701000798A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
UA17255S (uk) Автобус міжміський другого класу баз-а079.19
UA17253S (uk) Автобус міжміський другого класу баз-а079.14
UA17254S (uk) Автобус міжміський другого класу баз-а079.17
TH701000258A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701000200A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701000158A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH701000138A (th) สิทธิบัตรยังไม่ประกาศโฆษณา